X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-5-2023-58407.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2023-51785.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214010
https://www.accesswire.com/696227/CORRECTION-NGDI-UBC-Co-Founder-Adjunct-Professor-Kishor-Wasan-on-the-Example-of-Tropically-Stable-Amphotericin-B
https://www.globenewswire.com/news-release/2021/12/16/2353432/32419/en/Matinas-BioPharma-Announces-Unanimous-DSMB-Approval-to-Progress-into-Fourth-and-Final-Cohort-of-Patients-in-the-EnACT-Trial-of-MAT2203-Oral-Amphotericin-B-for-the-Treatment-of-Cryp.html
https://www.biospace.com/article/releases/matinas-biopharma-announces-positive-data-in-the-ongoing-enact-trial-of-mat2203-oral-amphotericin-b-for-the-treatment-of-cryptococcal-meningitis-exceeding-the-prespecified-primary-endpoint-threshold/?s=71
https://www.expresspharma.in/additional-61120-vials-of-liposomal-amphotericin-b-allocated-to-states-uts-and-central-institutions-gowda/
https://www.business-standard.com/article/health/61-000-more-vials-of-amphotericin-b-allocated-to-states-uts-centre-121062301153_1.html
https://www.business-standard.com/article/health/additional-5-240-vials-of-amphotericin-b-allocated-to-karnataka-121062300814_1.html
https://www.business-standard.com/article/health/have-sufficient-amphotericin-b-stock-for-treating-black-fungus-cases-govt-121061800929_1.html
https://www.expresspharma.in/govt-is-taking-steps-to-boost-availability-of-amphotericin-b-allots-6-67-lakh-vials-to-states-uts/
https://www.business-standard.com/article/health/black-fungus-106-300-vials-of-amphotericin-b-allocated-to-states-uts-121061400687_1.html
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/centre-issues-guidelines-for-management-of-black-fungus-in-kids-below-18/articleshow/83393945.cms
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/government-imposes-restrictions-on-export-of-amphotericin-b-injections/articleshow/83141278.cms
https://www.indiainfoline.com/article/news-top-story/gufic-biosciences-gets-nod-to-manufacture-and-market-liposomal-amphotericin-b-injection-121052000523_1.html
http://www.pharmabiz.com/NewsDetails.aspx?aid=138430&sid=1#:~:text=Government%20to%20ramp%20up%20availability%20of%20amphotericin%20B%20to%20treat%20mucormycosis,-Our%20Bureau%2C%20Mumbai&text=The%20Union%20ministry%20of%20chemicals,amphotericin%20B%20to%20fight%20mucormycosis.
https://www.globenewswire.com/news-release/2020/10/19/2110258/0/en/Matinas-BioPharma-Announces-Unanimous-DSMB-Approval-to-Progress-into-Second-Cohort-of-Patients-in-the-EnACT-Study-of-MAT2203-Oral-Amphotericin-B-for-the-Treatment-of-Cryptococcal-M.html
https://www.globenewswire.com/news-release/2020/02/19/1986897/0/en/Matinas-BioPharma-Announces-DSMB-Approval-to-Commence-Part-2-of-EnACT-Study-of-MAT2203-Oral-Amphotericin-B-for-the-Treatment-of-Cryptococcal-Meningitis.html
https://www.biospace.com/article/releases/matinas-biopharma-initiates-enact-study-of-mat2203-oral-amphotericin-b-for-the-treatment-of-fungal-cryptococcal-meningitis/?s=95
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-April-24-2019-1556080066.pdf
https://www.raps.org/news-and-articles/news-articles/2019/4/when-a-rems-is-necessary-fda-finalizes-guidance
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-17-2018-1516166737.pdf
http://www.in-pharmatechnologist.com/Processing/Gilead-ups-capacity-with-Cali-manufacturing-facility
https://www.pharmacompass.com/pdf/news/anvisa-suspended-three-lots-of-topical-antiseptic-riohex-1484910980.pdf
http://www.pharma-excipients.ch/2016/09/18/development-and-characterization-of-a-microemulsion-system-containing-amphotericin-b-with-potential-ocular-applications/
http://www.pharma-excipients.ch/2016/05/08/confusion-between-two-amphotericin-b-formulations-leading-to-a-paediatric-rehospitalisation/
http://health.economictimes.indiatimes.com/news/pharma/pharma-cos-probed-for-inefficient-generic-drugs/51218596
http://www.fiercedrugdelivery.com/story/fda-grants-fast-track-designation-oral-formulation-intravenous-antifungal-a/2015-08-25
http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0340-2015&w=01282015&lang=eng
Market Place
Share 
